Novartis/Nestle deal closes
This article was originally published in The Tan Sheet
Executive Summary
Nestle completed its acquisition of Novartis Medical Nutrition July 1 following "the successful conclusion of the regulatory process," Nestle announces. The Novartis unit and its roughly 2,000 employees will be integrated into Nestle Nutrition, Nestle says. "The acquisition propels Nestle into a strong number two position globally in the fast-growing and lucrative healthcare nutrition market, helping to accelerate the profitable development of the overall nutrition business," the firm adds. Plans for the transaction were announced in December (1"The Tan Sheet" Dec. 18, 2006, p. 8)...
You may also be interested in...
Nestle Looks To Cook Up Nutrition Product Sales With Novartis MN Acquisition
Nestle looks to become the number two company in the healthcare nutrition field, including the infant formula market, with its planned $2.5 bil. acquisition of Novartis' Medical Nutrition unit
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.